How genetic therapies transformed the lives of sickle cell patients
Their stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.
Mar 18, 2024
0
0
Their stories are divided into before and after. First, those long years of pain which flooded every moment—school, relationships, work.
Mar 18, 2024
0
0
March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people over age 45. It's the second-most common blood cancer and the most common blood cancer in Black people.
Mar 15, 2024
0
1
A method that enhances the functionality of an often-overlooked type of stem cell could lead to better treatments for blood-related diseases, according to new research.
Mar 14, 2024
0
64
A process of taking patients' own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study underway in Aurora is trying to determine whether ...
Mar 14, 2024
0
0
Researchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group, developed a method that makes it possible to detect early relapse of the blood ...
Mar 12, 2024
0
0
For thousands of Americans each year, a bone marrow transplant has the potential to cure diseases such as leukemias, lymphomas, and immune deficiency disorders. While lifesaving, bone marrow transplants are taxing procedures ...
Mar 12, 2024
0
0
Every year, more than 20,000 people in Germany die of blood cancer. It is the most common type of cancer in children. Donations of stem cells from blood or bone marrow increase the chance of survival for people suffering ...
Mar 11, 2024
0
0
Researchers at the University of Massachusetts Amherst recently released a first-of-its-kind study focusing on the rare autoimmune disorder aplastic anemia to understand how a subset of cells might be trained to correct the ...
Feb 27, 2024
0
0
A two-year follow-up clinical trial found that a new personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated strong safety and improved overall survival in patients, according to findings ...
Feb 27, 2024
0
0
Although immunologists have developed a deep reservoir of knowledge illuminating how antibodies respond to vaccination against SARS-CoV-2, little is known about the elusive cells that produce infection-fighting antibodies.